DRD2 rs770373484: Understanding This Genetic Variant
The rs770373484 variant is a specific genetic change located within the DRD2 gene, which plays a critical role in the brain's dopamine signaling pathways. Research into this gene is ongoing, as variants in this region are often studied for their potential influence on stress responses and behavioral health.
What each genotype means
Typical stress response profile
This genotype represents the most common genetic configuration for this specific variant in the general population. Current scientific literature provides limited evidence regarding how this specific variant influences stress response or dopamine signaling. Please note that genetic associations with complex traits like stress response are often influenced by many genes and environmental factors.
This is the most common genotype, found in the vast majority of the global population.
Typical stress response profile
Carrying one copy of the minor allele for this variant does not currently have a well-established clinical or functional impact on stress response pathways. Research into this specific DRD2 variant is limited, and it is not considered a primary driver of neurobiological stress differences. You should view this result as a minor genetic variation rather than a diagnostic indicator.
This genotype is extremely rare, occurring in approximately 1 in 150,000 individuals based on current population data.
Typical stress response profile
This genotype represents the homozygous minor state for this variant. Because the evidence strength for this variant's role in stress response is limited, there is no clear scientific consensus on how this genotype affects your biology. It is important to remember that most human traits are polygenic, meaning they are shaped by the interaction of many different genes and your life experiences.
This genotype is exceptionally rare, with a frequency estimated at less than 1 in 10 million individuals.
What is rs770373484?
The rs770373484 variant is a single nucleotide polymorphism (SNP) situated within the DRD2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The DRD2 gene provides instructions for creating the D2 dopamine receptor, a protein that sits on the surface of nerve cells. These receptors are essential for the transmission of dopamine, a neurotransmitter involved in reward, motivation, and motor control. Because this variant is located in a gene responsible for such fundamental neurological processes, researchers monitor it to see if it correlates with differences in how individuals process stress or respond to environmental stimuli. It is important to note that the presence of a specific SNP does not determine a person's health outcome, as most traits are influenced by a complex interplay of many genes, environmental factors, and lifestyle choices.
The Role of the DRD2 Gene
The DRD2 gene is a well-studied component of the human genome, primarily known for encoding the D2 subtype of the dopamine receptor. This receptor is a G-protein coupled receptor that helps regulate the activity of adenylyl cyclase, an enzyme involved in cellular signaling. By modulating dopamine levels, the D2 receptor helps the brain manage reward-seeking behavior, emotional regulation, and movement. Mutations or variations in this gene have been historically investigated in the context of various neuropsychiatric conditions, including schizophrenia, substance dependence, and movement disorders like myoclonus dystonia. Because dopamine is central to the brain's reward system, scientists often hypothesize that variations in DRD2 might influence how individuals experience stress or pleasure. However, the functional impact of any single variant, such as rs770373484, remains a subject of active scientific inquiry rather than established clinical fact.
Evidence and Scientific Context
The current evidence linking rs770373484 to specific health outcomes is considered limited. While the broader DRD2 gene has been extensively studied in relation to psychiatric and neurological disorders, individual SNPs often show varying levels of association depending on the population studied. Many studies on DRD2 variants have faced challenges, such as population stratification, where differences in genetic background between groups can lead to conflicting results. Furthermore, some associations reported in early literature have been difficult to replicate in larger, more diverse cohorts. Consequently, while the scientific community continues to explore the role of DRD2 in stress response and behavioral health, it is premature to draw definitive conclusions about the clinical significance of this specific variant. Researchers emphasize that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship for any individual.
Population Frequency
The rs770373484 variant is relatively rare in the general population, with a reported frequency of approximately 0.000003414. This low frequency suggests that the variant is not widely distributed across global populations. Because it is so uncommon, large-scale studies are required to gather enough data to understand its potential effects accurately. Genetic frequency can vary significantly between different ancestral groups, and researchers often look for these differences to better understand the evolutionary history and functional impact of specific variants. When a variant is this rare, it is often difficult to conduct robust statistical analyses, which contributes to the current limited state of evidence regarding its role in human health.
Interpreting Genetic Information
It is important to approach information about genetic variants like rs770373484 with a clear understanding of what it can and cannot tell you. Genetic data provides a snapshot of your biological blueprint, but it does not function as a medical diagnosis or a predictor of future behavior. If you have questions about your genetic results or concerns regarding stress, mental health, or medication response, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can help interpret your results within the context of your personal and family medical history. Never use genetic information to make changes to prescribed medications or treatment plans without first discussing them with your clinician or pharmacist. Science is an evolving field, and our understanding of how specific variants influence health will continue to grow as more research is conducted.
How common is this variant?
The rs770373484 variant is very rare, with a population frequency of approximately 0.000003414.
Frequently asked questions
What does the DRD2 gene do?
The DRD2 gene provides instructions for making the D2 dopamine receptor. This receptor is crucial for dopamine signaling, which helps regulate mood, reward, and movement in the brain.
Is rs770373484 associated with a specific disease?
There is currently limited evidence linking this specific variant to any disease. While the DRD2 gene is involved in various psychiatric conditions, the clinical impact of this particular SNP is not well-established.
Should I be worried if I have this variant?
No. Genetic variants are common, and most do not have a significant impact on your health. If you have concerns about your genetic results, you should discuss them with a healthcare provider.
Can I use this information to change my medication?
No. You should never change your medication or treatment plan based on genetic information without consulting your doctor or pharmacist first.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs770373484?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This SNP in the DRD2 gene is frequently studied in the context of psychiatric genetics, particularly regarding dopamine receptor expression and schizophrenia risk.
This variant has been studied for its association with schizophrenia and dopaminergic signaling.
The TaqIB polymorphism in the DRD2 gene is associated with dopamine receptor density and various behavioral and reward-related traits.
The DRD2 TaqIB variant modulates dopamine D2 receptor density and has been investigated for associations with addiction susceptibility and antipsychotic response.
A synonymous coding variant in exon 7 of DRD2 that affects mRNA stability, translation kinetics, and dopamine-related working memory and reward phenotypes.
Known as the DRD2 TaqID polymorphism, this variant alters D2 dopamine receptor gene structure and is implicated in altered striatal dopamine functioning and substance use behavior.